Ondansetron Tablet, Orally Disintegrating
Product Images NDC 51655-196

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 51655-196). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 196 80)

Ondansetron Orally Disintegrating Tablets, USP 8 mg, 8 tablets label from Northwind Health Company, LLC. The label shows prescribing details and storage conditions for this oral dosage form.*

FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical structure of Ondansetron depicted with labeled atoms and bonds, including a characteristic bicyclic ring and a methyl group attached to a nitrogen atom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.